Clinical Trials Browser

Phase 2 × Completed × Leukemia, T-Cell × Clear all

NCT04689659 2025-05-18

Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma

Phase 2 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Recurrence, Leukemia, T-Cell

NCT00611208 2016-11-29

A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)

Phase 2 Completed

DermatologicLymphoidOther hematologic neoplasm

Mycosis Fungoides, Sezary Syndrome, Leukemia, T-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous

NCT00095381 2012-01-19

Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, T-Cell